What stock options related to Vita Coco (COCO) does Kenneth Sadowsky hold?

Sadowsky holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of Vita Coco common stock. The option has an exercise price of $10.178 per share and an expiration date of January 2, 2030, as disclosed.

What price range did the Vita Coco (COCO) share sales occur within?

The filing notes the sale price is a weighted average, with individual trades executed between $56.54 and $57.77 per share. The reporting person has undertaken to provide full breakdowns of shares sold at each price upon request.

Vita Coco director sells 3,900 shares under plan

Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock at a weighted average price of $56.918 per share.

Accepted by SEC EDGAR 03/19/2026 - 04:06 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock at a weighted average price of $56.918 per share. The trade was executed pursuant to a pre-arranged Rule 10b5-1 trading plan, indicating it was scheduled in advance.

After the sale, Sadowsky directly holds 590,466 shares of common stock. He also holds a fully vested, currently exercisable non-qualified stock option to buy 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.

Insider Trade Summary 10b5-1

Net Seller: 3,900 shares

Net Sell 1 txn

Insider Sadowsky Kenneth

Role Director

Sold 3,900 shs ($222K)

Share of Position Sold 0.66%

Type	Security	Shares	Price	Value
Sale	Common Stock	3,900	$56.918	$222K
Holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 590,466 shares (Direct); Non-Qualified Stock Option (Right to Buy) — 27,300 contracts (Direct)

Holdings Before and After: Common Stock, 594,366 to 590,466 shares (Direct)

Other Insiders: 7 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (3)

F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.54 to $57.77, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3. The stock option is fully vested and currently exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vita Coco (COCO) director Kenneth Sadowsky report in this Form 4?

Kenneth Sadowsky reported selling 3,900 shares of Vita Coco common stock in an open-market transaction. The weighted average sale price was $56.918 per share, and the trade was carried out under a pre-arranged Rule 10b5-1 trading plan.

How many Vita Coco (COCO) shares did Kenneth Sadowsky sell and at what price?

He sold 3,900 shares of Vita Coco common stock at a weighted average price of $56.918 per share. The shares were sold in multiple trades within a price range from $56.54 to $57.77, according to the filing’s footnote.

How many Vita Coco (COCO) shares does Kenneth Sadowsky hold after this sale?

Following the reported sale, Kenneth Sadowsky directly owns 590,466 shares of Vita Coco common stock. This figure reflects his remaining direct equity stake after disposing of 3,900 shares in the open market on March 18, 2026.

Was the Vita Coco (COCO) stock sale by Kenneth Sadowsky under a Rule 10b5-1 plan?

Yes. The filing states that the sales of Vita Coco common stock were effected pursuant to a Rule 10b5-1 trading plan. Such plans allow insiders to pre-schedule trades, reducing the significance of trade timing as an indicator of sentiment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sadowsky Kenneth

(Last)

(First)

(Middle)

111 5TH AVENUE 2ND FLOOR

(Street)

NEW YORK

10003

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/18/2026		S⁽¹⁾		3,900	D	$56.918⁽²⁾	590,466	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (Right to Buy)	$10.178							⁽³⁾	01/02/2030	Common Stock	27,300		27,300	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.54 to $57.77, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

	/s/ Alison Klein, attorney-in-fact for Kenneth Sadowsky	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR